Netcall (NET) Competitors GBX 106 -3.00 (-2.75%) As of 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock NET vs. DOCS, WIX, YOU, CNIC, SRAD, GVP, SLP, ARBB, CYN, and INSEShould you be buying Netcall stock or one of its competitors? The main competitors of Netcall include Dr. Martens (DOCS), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), Stelrad Group (SRAD), Gabelli Value Plus+ Trust (GVP), Sylvania Platinum (SLP), Arbuthnot Banking Group (ARBB), CQS Natural Resources Growth and Income (CYN), and Inspired (INSE). These companies are all part of the "computer software" industry. Netcall vs. Dr. Martens Wickes Group YouGov CentralNic Group Stelrad Group Gabelli Value Plus+ Trust Sylvania Platinum Arbuthnot Banking Group CQS Natural Resources Growth and Income Inspired Netcall (LON:NET) and Dr. Martens (LON:DOCS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Does the media refer more to NET or DOCS? In the previous week, Dr. Martens had 3 more articles in the media than Netcall. MarketBeat recorded 3 mentions for Dr. Martens and 0 mentions for Netcall. Netcall's average media sentiment score of 0.00 beat Dr. Martens' score of -0.19 indicating that Netcall is being referred to more favorably in the media. Company Overall Sentiment Netcall Neutral Dr. Martens Neutral Which has more risk & volatility, NET or DOCS? Netcall has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Do analysts recommend NET or DOCS? Netcall currently has a consensus target price of GBX 130, indicating a potential upside of 22.64%. Dr. Martens has a consensus target price of GBX 6,000, indicating a potential upside of 10,566.67%. Given Dr. Martens' higher probable upside, analysts plainly believe Dr. Martens is more favorable than Netcall.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Netcall 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger earnings & valuation, NET or DOCS? Dr. Martens has higher revenue and earnings than Netcall. Dr. Martens is trading at a lower price-to-earnings ratio than Netcall, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNetcall£39.16M4.47£5.87M£3.5529.85Dr. Martens£874.20M0.62£68.97M£7.057.97 Is NET or DOCS a better dividend stock? Netcall pays an annual dividend of GBX 1 per share and has a dividend yield of 0.9%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.3%. Netcall pays out 28.2% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the MarketBeat Community prefer NET or DOCS? Netcall received 152 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 84.62% of users gave Dr. Martens an outperform vote while only 58.21% of users gave Netcall an outperform vote. CompanyUnderperformOutperformNetcallOutperform Votes16358.21% Underperform Votes11741.79% Dr. MartensOutperform Votes1184.62% Underperform Votes215.38% Do institutionals and insiders believe in NET or DOCS? 69.3% of Netcall shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 11.5% of Netcall shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is NET or DOCS more profitable? Netcall has a net margin of 14.99% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Netcall's return on equity.Company Net Margins Return on Equity Return on Assets Netcall14.99% 14.95% 4.62% Dr. Martens 7.89%18.91%8.12% SummaryNetcall and Dr. Martens tied by winning 10 of the 20 factors compared between the two stocks. Get Netcall News Delivered to You Automatically Sign up to receive the latest news and ratings for NET and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NET vs. The Competition Export to ExcelMetricNetcallSoftware IndustryComputer SectorLON ExchangeMarket Cap£175.21M£5.33B£25.07B£2.68BDividend Yield0.79%3.20%2.89%5.05%P/E Ratio29.8528.4944.60134.32Price / Sales4.47275.872,088.05203,702.45Price / Cash7.3516.6334.7828.02Price / Book4.329.636.653.79Net Income£5.87M£63.43M£739.99M£5.89B7 Day Performance-6.19%-0.34%-0.99%7.78%1 Month Performance-3.64%12.67%14.39%29.45%1 Year Performance22.38%9.38%52,549.95%119.74% Netcall Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NETNetcall1.4722 of 5 starsGBX 106-2.8%GBX 130+22.6%+22.4%£175.21M£39.16M29.853,220DOCSDr. Martens2.8701 of 5 starsGBX 59+2.3%N/A-32.0%£572.75M£874.20M8.36890News CoverageDividend CutAnalyst ForecastGap UpWIXWickes Group2.2522 of 5 starsGBX 214.50+8.8%GBX 189-11.9%+53.3%£507.87M£1.45B17.345,930Analyst ForecastYOUYouGov2.822 of 5 starsGBX 300.23-1.6%GBX 880+193.1%-64.9%£351.31M£335.28M-153.011,820CNICCentralNic GroupN/AN/AN/AN/A£339.82M£790.04M-12,660.00100SRADStelrad GroupN/AGBX 136+3.8%N/A+9.3%£180.68M£306.97M11.692,960Gap UpGVPGabelli Value Plus+ TrustN/AN/AN/AN/A£155.29MN/A0.00310Gap DownSLPSylvania PlatinumN/AGBX 47.20-0.4%N/A-25.4%£152.33M£99.97M22.12160Positive NewsARBBArbuthnot Banking GroupN/AGBX 900-1.4%N/A-6.2%£145.68M£239.83M4.76799Gap UpCYNCQS Natural Resources Growth and IncomeN/AGBX 199.30+0.2%N/A-2.3%£125.32M£12.63M14.1640INSEInspiredN/AGBX 68.67-1.2%N/A-26.1%£109.62M£155.87M62.871,600 Related Companies and Tools Related Companies DOCS Competitors WIX Competitors YOU Competitors CNIC Competitors SRAD Competitors GVP Competitors SLP Competitors ARBB Competitors CYN Competitors INSE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NET) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Netcall plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Netcall With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.